Penn Medicine Launches Clinical Trial For Uterine Transplants

PHILADELPHIA (CBS) — Penn Medicine announced this week that it will perform uterine transplants as part of a multi-year clinical trial.

It’s aimed at offering women who lack or have a damaged womb a chance to bear children.

“Infertility in general has a lot of great treatments with in vitro fertilization, but women with Uterine Factor Infertility don’t have any effective treatment,” said Co-investigator Dr. Kate O’Neill said.

She says if they can successfully perform uterine transplants from deceased donors, the study moves into the second phase.

“In that phase of the trial, we are performing embryo transfers in these individuals with stable uterine transplants,” she explained.

To allow the recipient to stop drugs that block rejection, the uterus is essentially on loan.

“Once they’ve completed their childbearing, we actually remove the uterus,” said O’Neill.

Participants will then be followed for 5 to 10 years. It’s a big undertaking.

“Just having the option available, I think, changes lives,” O’Neill said.

This site uses cookies, tokens, and other third party scripts to recognize visitors of our sites and services, remember your settings and privacy choices, and — depending on your settings and privacy choices — enable us and some key partners to collect information about you so that we can improve our services and deliver relevant ads.

By continuing to use our site or clicking Agree, you agree that CBS and our key partners may collect data and use cookies for personalized ads and other purposes, as described more fully in our privacy policy. You can change your settings at any time by clicking Manage Settings.